11 October 2021 at 7:00 PM GST
THE AWARD WINNERS’ WEBINARS SERIES
Neurological Diseases
Loading
The Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences was established in 1999 to honor scientists who have tirelessly pursued distinctive medical research that serves the interests of humanity. In this regard, the Award recognizes excellence through the greatly diversified international, regional and local awards. These efforts have paid off well, as two of the Grand Hamdan Award winners were awarded the Nobel Prize in Physiology in 2010 and 2020; SIR ROBERT G EDWARDS & DR. HARVEY J ALTER.
Today, we are organizing this new series of virtual activities to revisit the relevant Awards topics, to examine the scientific advances in each field, and to explore the winners’ new interests in the rapidly evolving scientific world.
This webinar will host PROF. CHRISTIAN HAASS, chair of Biochemistry, Medical Faculty of the Ludwig-Maximilians University in Munich, Germany, and Winner of the Hamdan Award for Medical Research Excellence in 2005-2006 for “Cytokines in Pathogenesis & Therapy of Diseases”. Prof. Haass is the speaker of the German Center for Neurodegenerative Diseases (DZNE-Munich) and the Munich Cluster for Systems Neurology (SyNergy).
Prof. Haass received many prestigious awards, among them the Potemkin Award of the American Academy of Neurology, the Sheik Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, the MetLife Award, the Brain Prize, and the Gottfried Wilhelm Leibniz-Award of the DFG. He is a member of the European Molecular Biology Organization (EMBO), the Leopoldina (German Academy of Sciences) and the Bavarian Academy of Sciences.
Prof. Haass talk about the Microglial Modulation in Alzheimer’s disease - innovative therapies or devilish gambling.
The webinar will also host Dr. Suhail Abdulla Al-Rukn as chairperson. He is Consultant Neurologist, Head of Stroke Program, and Director of Neurology Residency Program at Rashid Hospital, DHA. Currently he serves as the President of Emirates Neurology Society and MENA Stroke Organization. He sits on the executive boards of various scientific associations, steering committee and advisory boards.
Chair of Biochemistry, Medical Faculty of the Ludwig-Maximilians University- Munich, Germany.
Winner of the Hamdan Award for Medical Research Excellence 2005-2006.
Christian Haass holds the chair of Biochemistry at the Medical Faculty of the Ludwig-Maximilians-University in Munich, Germany. In addition, he is the speaker of the German Center for Neurodegenerative Diseases (DZNE-Munich) and the Munich Cluster for Systems Neurology (SyNergy).
He completed his undergraduate work at the University of Heidelberg and graduated at the Center for Molecular Biology (ZMBH) with highest honors. He trained with a postdoctoral fellowship of the DFG (German Research Foundation) at the Center for Neurologic Diseases in the Selkoe laboratory at the Harvard Medical School. Within two years he was appointed to Assistant Professor of Neurology at Harvard. In 1999 he returned to Germany, where he first was appointed as a Professor of Molecular Biology at the Central Institute of Mental Health, Mannheim and four years later as the chairman of the Department of Metabolic Biochemistry of the Ludwigs-Maximilians-University Munich.
Dr. Haass’ research focuses on the cellular and molecular mechanisms of Alzheimer’s disease and related disorders. He discovered the molecular mechanisms allowing physiological production of Amyloid -peptide and identified biological and pathological functions of secretases. His laboratory was also the first to reconstitute the -secretase complex. More recently, Haass focusses on protective functions of microglia, which he attempts to therapeutically modify with selective antibodies. Haass received many prestigious awards, among them the Potemkin Award of the American Academy of Neurology, the Sheik Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, the MetLife Award, the Brain Prize, and the Gottfried Wilhelm Leibniz-Award of the DFG. He is a member of the European Molecular Biology Organization (EMBO), the Leopoldina (German Academy of Sciences) and the Bavarian Academy of Sciences.
MD, FRCPC, President of Emirates Neurology Society, Consultant Neurologist, Head of Stroke Program, Director of Neurology Residency Program, Rashid Hospital, DHA, Dubai.
Dr. AlRukn received his degree in medicine from UAE university. He underwent his neurology residency at the University of McGill, and subsequently obtain the neurology certification from the Royal Collage of Physicians & Surgeon (Canada). He then completed a fellowship in Cerebrovascular disease and Stroke at Montreal General Hospital, Canada. he currently serves as a head of Stroke Center at Rashid Hospital, Dubai.
Dr. AlRukn’ s field of interest are principally directed towards the acute stroke management, stroke unit establishing and post stroke rehabilitation. He established the 1st certified stroke unit in UAE. Dr. Al Rukn is a local and international speakers in stroke field, and had many publications in this area. Currently he is the President of MENA Stroke Organization. In 2019, Dr. AlRukn became the President of World Congress of Neurology, and is the currently the President of Emirates Neurology Society.
Dr. AlRukn is the Founder and the chairman of the Neurology Residency Program in Dubai, since 2013. Also, he is the Chairman of the Dubai Scientific & Research Ethical Committee. Dr. AlRukn has an interest in Headache management & Movement disorders, and he is running the movement disorder clinic at Rashid hospital. He currently sits on the executive boards of various scientific associations, steering committee and advisory boards, mainly in stroke & headache.
